Chemists broke a 100-year-old rule to make extremely unstable molecules
Scientists have just broken a 100-year-old chemistry rule and synthesized a type of 3D, unstable molecule called an anti-Bredt olefin.
Get the world’s most fascinating discoveries delivered straight to your inbox.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered Daily
Daily Newsletter
Sign up for the latest discoveries, groundbreaking research and fascinating breakthroughs that impact you and the wider world direct to your inbox.
Once a week
Life's Little Mysteries
Feed your curiosity with an exclusive mystery every week, solved with science and delivered direct to your inbox before it's seen anywhere else.
Once a week
How It Works
Sign up to our free science & technology newsletter for your weekly fix of fascinating articles, quick quizzes, amazing images, and more
Delivered daily
Space.com Newsletter
Breaking space news, the latest updates on rocket launches, skywatching events and more!
Once a month
Watch This Space
Sign up to our monthly entertainment newsletter to keep up with all our coverage of the latest sci-fi and space movies, tv shows, games and books.
Once a week
Night Sky This Week
Discover this week's must-see night sky events, moon phases, and stunning astrophotos. Sign up for our skywatching newsletter and explore the universe with us!
Join the club
Get full access to premium articles, exclusive features and a growing list of member rewards.
Scientists have broken a 100-year-old chemistry rule to synthesize a class of molecules previously thought to be too unstable to form.
The molecules in question violate Bredt's rule, which describes where certain types of bonds can occur within a class of 3D chemical compounds. Successfully synthesizing these "anti-Bredt" molecules, as described Nov. 1 in the journal Science, could help scientists make new kinds of medicine.
"If there's a rule that says something absolutely is impossible, then maybe you just haven't thought of the right way of solving it. And if you do it, it actually might not be as difficult as you think," study first author Luca McDermott, an organic chemist at UCLA, told Live Science.
The anti-Bredt molecules fall into a class of compounds known as olefins. Olefins have at least one double bond — a strong chemical bond made from two pairs of electrons — connecting two carbon atoms. Each of those carbon atoms usually lies in the same 2D plane as the other atoms to which it's bonded.
Early in the 20th century, German chemist Julius Bredt studied double bonds in bicyclic molecules, a group of chemicals that contain two ring-shaped structures stuck together. To get an idea of the shape of these bicyclic molecules, imagine folding two five-sided sticky notes in half and sticking them together back to back. You'd end up with a roughly Y-shaped 3D structure.
Related: Inside the 20-year quest to unravel the bizarre realm of 'quantum superchemistry'
Bredt's rule, based on his observations in the laboratory, states that the carbon atoms at the junctions of that "Y" — otherwise known as the bridgehead position — can't have a double bond. Since the bridgehead carbon and its surrounding atoms don't all lie in the same plane, Bredt predicted that introducing a double bond at the bridgehead position would make the molecule too unstable to exist.
Get the world’s most fascinating discoveries delivered straight to your inbox.
Now, McDermott and his colleagues have come up with a way to make anti-Bredt olefins and used the method to synthesize complex 3D molecules. Because the anti-Bredt olefins are unstable and highly reactive, the team wasn't able to isolate them directly in the new study. Instead, they added other molecules that could immediately react with the anti-Bredt olefins and form more stable products. That allowed them to experiment with several different variations on anti-Bredt olefins and their more stable products.
Reactions using anti-Bredt olefins could open doors to new types of medicines, study co-author Neil Garg, a professor and chemist at UCLA, told Live Science. The rigid, 3D structures could interact better with proteins in the body than existing flat medicinal compounds, he suggested.
The researchers said they plan to synthesize more compounds with unusual structures and explore new types of reactivity in the future.
"If we can question [Bredt's rule] after 100 years and push the limits of it, there's probably all sorts of other rules that are waiting to be reexamined," Garg said.

Skyler Ware is a freelance science journalist covering chemistry, biology, paleontology and Earth science. She was a 2023 AAAS Mass Media Science and Engineering Fellow at Science News. Her work has also appeared in Science News Explores, ZME Science and Chembites, among others. Skyler has a Ph.D. in chemistry from Caltech.
